AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease
- 11 November 2015
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 7 (313) , 313ra180
Abstract
The most common form of the childhood neurodegenerative disease late infantile neuronal ceroid lipofuscinosis (also called Batten disease) is caused by deficiency of the soluble lysosomal enzyme tripeptidyl peptidase 1 (TPP1) resulting from mutations in the TPP1 gene. We tested whether TPP1 gene transfer to the ependyma, the epithelial lining of the brain ventricular system, in TPP1-deficient dogs would be therapeutically beneficial. A one-time administration of recombinant adeno-associated virus (rAAV) expressing canine TPP1 (rAAV.caTPP1) resulted in high expression of TPP1 predominantly in ependymal cells and secretion of the enzyme into the cerebrospinal fluid leading to clinical benefit. Diseased dogs treated with rAAV.caTPP1 showed delays in onset of clinical signs and disease progression, protection from cognitive decline, and extension of life span. By immunostaining and enzyme assay, recombinant protein was evident throughout the brain and spinal cord, with correction of the neuropathology characteristic of the disease. This study in a naturally occurring canine model of TPP1 deficiency highlights the utility of AAV transduction of ventricular lining cells to accomplish stable secretion of recombinant protein for broad distribution in the central nervous system and therapeutic benefit.Keywords
Funding Information
- NIH (NS068099, NS077516, EY023968)
- Roy J. Carver Trust
- Batten Disease Support and Research Association
- Children's Hospital of Philadelphia Research Institute
- Jasper Against Batten Fund at Partnership for Cures
- Blake's Purpose Foundation
This publication has 34 references indexed in Scilit:
- A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy DogsHuman Gene Therapy, 2012
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's DiseaseMolecular Therapy, 2011
- A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosisGenes, Brain and Behavior, 2011
- Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)Neurology, 2011
- Cilia Organize Ependymal Planar PolarityJournal of Neuroscience, 2010
- High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiencyGene Therapy, 2009
- Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis by CNS Administration of a Serotype 2 Adeno-Associated Virus Expressing CLN2 cDNAHuman Gene Therapy, 2008
- Functional Correction of CNS Phenotypes in a Lysosomal Storage Disease Model Using Adeno-Associated Virus Type 4 VectorsJournal of Neuroscience, 2005
- Adult Ependymal Cells Are Postmitotic and Are Derived from Radial Glial Cells during EmbryogenesisThe Journal of Neuroscience, 2005
- The ependyma: A protective barrier between brain and cerebrospinal fluidGlia, 1995